SCHEMBL21036053

SCHEMBL21036053

c1ccc(-c2ccc3c(c2)c2ccccc2c2c4ccc(-c5ccc(-c6ccc7c(c6)oc6ccccc67)cc5)cc4c4ccccc4c32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.48
PLA2G4A P47712 5/20 0.48
AHR P35869 2/20 0.47
MMP12 P39900 1/20 0.47
MMP13 P45452 1/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
MAPT P10636 3/20 0.46
HPGD P15428 3/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HCRTR1 O43613 1/20 0.43
PLA2G10 O15496 1/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
CA12 O43570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21036052 1.00 PLA2G2A (0.48) PLA2G2APLA2G4AAHRMMP12MMP13
SCHEMBL21036055 0.97 AHR (0.50) PLA2G2APLA2G4AAHRMMP12MMP13
SCHEMBL25081970 0.95 PLA2G2A (0.48) PLA2G2APLA2G4AAHRMMP12MMP13
SCHEMBL21036050 0.95 AHR (0.52) PLA2G2APLA2G4AAHRMMP12MMP13
SCHEMBL18961019 0.95 AHR (0.52) PLA2G2APLA2G4AAHRMMP12MMP13
SCHEMBL21036051 0.95 AHR (0.52) PLA2G2APLA2G4AAHRMMP12MMP13
SCHEMBL21035454 0.94 PLA2G2A (0.43) PLA2G2APLA2G4AAHRMMP12MMP13
SCHEMBL21035274 0.93 PLA2G2A (0.51) PLA2G2APLA2G4AAHRMMP12MMP13
SCHEMBL21035276 0.93 PLA2G2A (0.51) PLA2G2APLA2G4AAHRMMP12MMP13
SCHEMBL25082027 0.93 AHR (0.50) PLA2G2APLA2G4AAHRMMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT JNC CORPORATION (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT TCF4, LGR4, OR51E2 PLA2G2A 2960/4885PLA2G4A 2931/4885AHR 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.